Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RABEAM study.

Details

Language :

English

ISSN :

00034967

Volume :

76

Issue :

11

Database :

Complementary Index

Journal :

Annals of the Rheumatic Diseases

Publication Type :

Academic Journal

Accession number :

125575523

Full Text :

https://doi.org/10.1136/annrheumdis-2017-211259